09-23 Waters Corporation Presents at U.S. All Stars Conference, Sep-23-2026 11:00 AM
09-21 Goldman Sachs Adjusts Price Target on Waters to $515 From $465, Maintains Buy Rating MT
09-16 Everlywell Announces Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. to Patients CI
09-14 Waters Corporation Announces Global Commercial Launch of BD FACSDiscover A7 Cell Analyzer CI
09-14 Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer PR
09-14 Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer AQ
09-11 Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference PR
09-09 Waters Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 10:15 AM
09-09 UBS Upgrades Waters to Buy From Neutral, Adjusts Price Target to $490 From $375 MT
09-03 Baird Adjusts Price Target on Waters to $456 From $434, Keeps Outperform Rating MT
09-01 HSBC Adjusts Price Target on Waters to $455 From $450, Maintains Buy Rating MT
08-27 Waters Shares Rise After Piper Sandler Upgrade MT
08-27 Piper Sandler Upgrades Waters to Overweight From Neutral, $480 Price Target MT
08-26 Waters Corporation to Present at the Wells Fargo Healthcare Conference PR
08-24 Waters' Q4 Guide Conservative, 2027 Growth Could Reach High Single Digits, RBC Says MT
08-21 Waters Corporation Announces Executive Changes CI
08-11 Tranche Update on Waters Corporation's Equity Buyback Plan announced on January 23, 2019. CI
08-05 Goldman Sachs Adjusts Waters Price Target to $465 From $425 MT
08-05 JPMorgan Adjusts Waters Price Target to $400 From $370 MT
08-05 Wells Fargo Adjusts Waters Price Target to $400 From $370 MT
08-05 Stifel Nicolaus Adjusts Waters Price Target to $420 From $380 MT
08-05 RBC Capital Adjusts Waters Price Target to $475 From $435, Maintains Outperform Rating MT
08-05 Deutsche Bank Adjusts Waters Price Target to $400 From $380, Maintains Hold Rating MT
08-05 Barclays Adjusts Price Target on Waters to $460 From $425, Maintains Overweight Rating MT
08-05 Evercore ISI Adjusts Price Target on Waters to $420 From $410, Maintains Outperform Rating MT
No results match your criteria